Optimind Pharma Corp. reported earnings results for the second quarter and six months ended August 31, 2023. For the second quarter, the company reported sales was CAD 0.027353 million compared to CAD 0.027618 million a year ago. Net loss was CAD 0.183497 million compared to CAD 0.649508 million a year ago. Basic loss per share from continuing operations was CAD 0.002 compared to CAD 0.009 a year ago.
For the six months, sales was CAD 0.068626 million compared to CAD 0.067615 million a year ago. Net loss was CAD 0.587157 million compared to CAD 0.778003 million a year ago. Basic loss per share from continuing operations was CAD 0.006 compared to CAD 0.011 a year ago.